These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29374717)

  • 1. Effect of Neoadjuvant Chemoradiotherapy on Lymph Node Micrometastases in Thoracic Esophageal Cancer.
    Yanagi M; Sasaki K; Uchikado Y; Omoto I; Arigami T; Kurahara H; Uenosono Y; Sakoda M; Maemura K; Natsugoe S
    Anticancer Res; 2018 Feb; 38(2):893-900. PubMed ID: 29374717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neoadjuvant chemotherapy on primary tumor and lymph node metastasis in esophageal squamous cell carcinoma: additive association with prognosis.
    Akita H; Doki Y; Yano M; Miyata H; Miyashiro I; Ohigashi H; Ishikawa O; Nishiyama A; Imaoka S
    Dis Esophagus; 2009; 22(4):291-7. PubMed ID: 19021686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of lymphovascular invasion in patients with esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
    Chen WH; Huang YL; Chao YK; Yeh CJ; Chang HK; Tseng CK; Liu YH
    Ann Surg Oncol; 2015 Jan; 22(1):338-43. PubMed ID: 25023545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
    Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
    BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma.
    Hiraki Y; Kimura Y; Imano M; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Makino T; Motoori M; Yamasaki M; Miyata H; Satou T; Satoh T; Furukawa H; Yano M; Doki Y; Yasuda T
    Surg Today; 2021 Jan; 51(1):118-126. PubMed ID: 32596796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of lymph node metastases in early esophageal carcinoma and treatment regimens].
    Li L; Liu SY; Zhu KS; Chen JQ; Ying MG
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):226-9. PubMed ID: 19615267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new classification of lymph node metastases according to the lymph node stations for predicting prognosis in surgical patients with esophageal squamous cell carcinoma.
    Lin Z; Chen W; Chen Y; Peng X; Zhu K; Lin Y; Lin Q; Hu Z
    Oncotarget; 2016 Nov; 7(46):76261-76273. PubMed ID: 27788489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Predictors of Unsuspected Recurrent Laryngeal Nerve Lymph Node Metastases After Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma.
    Li ZG; Zhang XB; Wen YW; Liu YH; Chao YK
    World J Surg; 2018 Aug; 42(8):2485-2492. PubMed ID: 29380005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Leng X; He W; Yang H; Chen Y; Zhu C; Fang W; Yu Z; Mao W; Xiang J; Chen Z; Yang H; Wang J; Pang Q; Zheng X; Liu H; Yang H; Li T; Zhang X; Li Q; Wang G; Mao T; Guo X; Lin T; Liu M; Fu J; Han Y
    Ann Surg; 2021 Dec; 274(6):e1022-e1029. PubMed ID: 31855875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
    Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
    Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Ibuki Y; Yamakita I; Kurokawa T; Okada M
    Anticancer Res; 2017 Oct; 37(10):5639-5646. PubMed ID: 28982881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
    Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M
    Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neoadjuvant chemotherapy on lymph node micrometastases in squamous cell carcinomas of the thoracic esophagus.
    Matsuyama J; Doki Y; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Yamasaki M; Makari Y; Matsuura N; Mano M; Monden M
    Surgery; 2007 May; 141(5):570-80. PubMed ID: 17462456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Impact of Extracapsular Lymph Node Involvement in Esophageal Squamous Cell Carcinoma.
    Lin CM; Tu CC; Yeh YC; Hsu PK; Chien LI; Huang CS; Wu YC; Hsu HS
    Ann Surg Oncol; 2020 Aug; 27(8):3071-3082. PubMed ID: 32080808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial.
    Robb WB; Dahan L; Mornex F; Maillard E; Thomas PA; Meunier B; Boige V; Pezet D; Le Brun-Ly V; Bosset JF; Mabrut JY; Triboulet JP; Bedenne L; Seitz JF; Mariette C;
    Ann Surg; 2015 May; 261(5):902-8. PubMed ID: 25361220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus.
    Lee T; Tanaka H; Ohira M; Kubo N; Sakurai K; Toyokawa T; Muguruma K; Yamashitaz Y; Maeda K; Hirakawa K
    Hepatogastroenterology; 2014; 61(133):1235-40. PubMed ID: 25436289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.
    Guan H; Yu Y; Ge H; Zhu S; Huang W; Li B
    Future Oncol; 2019 Oct; 15(29):3345-3355. PubMed ID: 31578872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.